Loss of Modifier of Cell Adhesion Reveals a Pathway Leading to Axonal Degeneration
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Axonal dysfunction is the major phenotypic change in many neurodegenerative diseases, but the processes underlying this impairment are not clear. Modifier of cell adhesion (MOCA) is a presenilin binding protein that functions as a guanine nucleotide exchange factor for Rac1. The loss of MOCA in mice leads to axonal degeneration and causes sensorimotor impairments by decreasing cofilin phosphorylation and altering its upstream signaling partners LIM kinase and p21-activated kinase, an enzyme directly downstream of Rac1. The dystrophic axons found in MOCA-deficient mice are associated with abnormal aggregates of neurofilament protein, the disorganization of the axonal cytoskeleton, and the accumulation of autophagic vacuoles and polyubiquitinated proteins. Furthermore, MOCA deficiency causes an alteration in the actin cytoskeleton and the formation of cofilin-containing rod-like structures. The dystrophic axons show functional abnormalities, including impaired axonal transport. These findings demonstrate that MOCA is required for maintaining the functional integrity of axons and define a model for the steps leading to axonal degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625 · cited 4×
“Some axonal swellings are filled with autophagic structures resulting from the failure of lysosomal-mediated organelle transport and protein degradation (Nixon, 2006; Rubinsztein, 2006).”
BackgroundInfluentialMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 2×
“Iba1 is a Ca 2 -binding protein produced by monocytes and microglia, and alterations in its expression are associated with inflammation (Ito et al., 1998).”
BackgroundAxonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107 · cited 1×
“For example, in many mutations that are linked to motor neuropathies, axons are the only major disease target (Pasinelli and Brown, 2006).”
BackgroundMacroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967 · cited 13×
“The mice have sensorimotor impairments and structural changes that include axonal swellings containing NFs and AVs in several brain regions including the spinal cord and cerebellum.”
BackgroundInfluentialAxon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819 · cited 4×
“…that interrupt the continuity of axons of dysfunctional or degenerating neurons, is a hallmark of many neurological disorders, including Alzheimer’s disease (AD), Huntington’s disease, amyotrophic lateral sclerosis, and Charcot-Marie-Tooth disease (Medana and Esiri, 2003; Coleman, 2005).”
BackgroundInfluentialPrecursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
Koo, E. H., Sisodia, S. S., Archer, D. R., Martin, L. J., Weidemann, A., Beyreuther, K., Fischer, P., Masters, C. L., & Price, D. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1561 · Cited by 733
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
Petzold, A. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.015 · Cited by 688
Kamal, A., Stokin, G. B., Yang, Z., Xia, C.-H., & Goldstein, L. S. B. (2000) · Neuron · doi:10.1016/s0896-6273(00)00124-0 · Cited by 544 · cited 1×
“APP is transported in a fast anterograde manner within axons (Koo et al., 1993; Kamal et al., 2000; Lazarov et al., 2005; Stokin et al., 2005).”
BackgroundEffects of PS1 Deficiency on Membrane Protein Trafficking in Neurons
Naruse, S., Thinakaran, G., Luo, J.-J., Kusiak, J. W., Tomita, T., Iwatsubo, T., Qian, X., Ginty, D. D., Price, D. L., Borchelt, D. R., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80637-6 · Cited by 355 · cited 1×
“PS is involved in APP trafficking (Naruse et al., 1998; Cai et al., 2003) and PSmutationsimpairAPPaxonaltransport (Piginoetal.,2003;Lazarovetal.,2007).”
BackgroundAxonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited
Lazarov, O., Morfini, G. A., Lee, E. B., Farah, M. H., Szodorai, A., DeBoer, S. R., Koliatsos, V. E., Kins, S., Lee, V. M.-Y., Wong, P. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3089-04.2005 · Cited by 239
Grimsley, C. M., Kinchen, J. M., Tosello-Trampont, A.-C., Brugnera, E., Haney, L. B., Lu, M., Chen, Q., Klingele, D., Hengartner, M. O., & Ravichandran, K. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307087200 · Cited by 224 · cited 8×
“Importantly, the regulation of cofilin is downstream of Rac1, and MOCA is a GEF that mediates Rac1 activity (Grimsley et al., 2004).”
BackgroundInfluentialSelf-citationSynaptic remodeling during aging and in Alzheimer's disease
Masliah, E., Crews, L., & Hansen, L. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s311 · Cited by 132 · cited 1×
“In human AD brains, loss of synapses is widely distributed, whereas neuronal loss is selective and localized (Masliah et al., 2006).”
BackgroundAge-dependent axonal degeneration in an Alzheimer mouse model
Wirths, O., Weis, J., Kayed, R., Saido, T. C., & Bayer, T. A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.07.021 · Cited by 127
MOCA Induces Membrane Spreading by Activating Rac1
Namekata, K., Enokido, Y., Iwasawa, K., & Kimura, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311275200 · Cited by 84 · cited 2×
“(cid:1) -gal expression is detected in all regions of the CNS, consistent with the MOCA gene expression pattern shown previously (Kashiwa et al., 2000; Namekata et al., 2004).”
BackgroundResultEndogenous Presenilin-1 Targets to Endocytic Rather Than Biosynthetic Compartments
Lah, J. J., & Levey, A. I. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0861 · Cited by 84 · cited 1×
“Subcellular fractionation of spinal cord extracts was performed as described with some modification (Kim et al., 2000; Lah and Levey, 2000; Leem et al., 2002; Gandy et al., 2007).”
MethodA novel mechanism for the regulation of amyloid precursor protein metabolism
Chen, Q., Kimura, H., & Schubert, D. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110151 · Cited by 63 · cited 2×
“MOCA regulates metabolism of cell adhesion proteins, such as amyloid precursor protein (APP) and N-cadherin, and is also involved in modulating neurite growth (Chen et al., 2002, 2005).”
BackgroundSelf-citationLinking Lysosomal Trafficking Defects with Changes in Aging and Stress Response in Drosophila
Simonsen, A., Cumming, R. C., & Finley, K. D. (2007) · Autophagy · doi:10.4161/auto.4604 · Cited by 37
Cited by
Dock-family exchange factors in cell migration and disease
Gadea, G., & Blangy, A. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.06.003 · Cited by 217
Insights into the biological functions of Dock family guanine nucleotide exchange factors
Laurin, M., & Côté, J.-F. (2014) · Genes & Development · doi:10.1101/gad.236349.113 · Cited by 160
Gain‐of‐function ADCY5 mutations in familial dyskinesia with facial myokymia
Chen, Y., Friedman, J. R., Chen, D., Chan, G. C. ‐., Bloss, C. S., Hisama, F. M., Topol, S. E., Carson, A. R., Pham, P. H., Bonkowski, E. S., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24119 · Cited by 126
“DOCK3 (OMIM #603123) is a guanine nucleotide exchange factor, primarily expressed in neurons and testis, which is involved in axonal transport by promoting cytoskeletal reorganization.(16,17) Dock3 null mice present with central axonal dystrophy, a concomitant loss of sensorimotor function, and impaired axoplasmic flo…”
BackgroundSelf-citationDOCK7 interacts with TACC3 to regulate interkinetic nuclear migration and cortical neurogenesis
Yang, Y.-T., Wang, C.-L., & Van Aelst, L. (2012) · Nature Neuroscience · doi:10.1038/nn.3171 · Cited by 97
“Also, non-redundant functions for several DOCK180 family members have been previously reported 41–43 .”
Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex
Namekata, K., Harada, C., Taya, C., Guo, X., Kimura, H., Parada, L. F., & Harada, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914514107 · Cited by 84
Metadata
- Authors
- Chen, Q., Peto, C. A., Shelton, G. D., Mizisin, A., Sawchenko, P. E., & Schubert, D.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-01-07
- Volume
- 29
- Issue
- 1
- Pages
- 118-130
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2046136650
- Cited by
- 66
- References
- 18
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.